PVLA: FDA Grants Rolling Review
Palvella's QTORIN Rapamycin NDA for Microcystic Lymphatic Malformations receives rolling review from FDA
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.